Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
245.02
-0.67 (-0.27%)
Nov 22, 2024, 4:00 PM EST - Market closed

Cencora Revenue

In the fiscal year ending September 30, 2024, Cencora had annual revenue of $293.96B with 12.12% growth. Cencora had revenue of $79.05B in the quarter ending September 30, 2024, with 14.69% growth.

Revenue (ttm)
$293.96B
Revenue Growth
+12.12%
P/S Ratio
0.17
Revenue / Employee
$6,390,404
Employees
46,000
Market Cap
48.03B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024293.96B31.79B12.12%
Sep 30, 2023262.17B23.59B9.89%
Sep 30, 2022238.59B24.60B11.50%
Sep 30, 2021213.99B24.09B12.69%
Sep 30, 2020189.89B10.30B5.74%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CVS Health 367.25B
McKesson 330.19B
GSK 41.97B
Takeda Pharmaceutical 31.73B
Becton, Dickinson and Company 19.83B
GE HealthCare Technologies 19.56B
Haleon 15.07B
Alcon 9.76B
Revenue Rankings